Balentine LLC’s Ovintiv OVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,689
Closed -$243K 447
2024
Q1
$243K Buy
+4,689
New +$214K 0.01% 448
2023
Q4
Sell
-4,938
Closed -$235K 603
2023
Q3
$235K Buy
+4,938
New +$224K 0.01% 427
2023
Q1
Sell
-4,117
Closed -$209K 659
2022
Q4
$209K Buy
+4,117
New +$215K 0.01% 531
2022
Q2
Sell
-5,905
Closed -$319K 678
2022
Q1
$319K Sell
5,905
-79
-1% -$3.4K 0.01% 417
2021
Q4
$202K Sell
5,984
-833
-12% -$29.7K 0.01% 340
2021
Q3
$224K Sell
6,817
-214
-3% -$5.91K 0.01% 225
2021
Q2
$221K Sell
7,031
-5,120
-42% -$138K 0.01% 154
2021
Q1
$289K Sell
12,151
-356
-3% -$7.62K 0.01% 113
2020
Q4
$180K Hold
12,507
0.01% 131
2020
Q3
$102K Hold
12,507
0.01% 122
2020
Q2
$119K Buy
12,507
+10,442
+506% +$72.8K 0.01% 135
2020
Q1
$6K Buy
2,065
+1,736
+528% +$22.8K ﹤0.01% 464
2019
Q4
$8K Hold
329
﹤0.01% 380
2019
Q3
$8K Sell
329
-155
-32% -$3.55K ﹤0.01% 409
2019
Q2
$12K Buy
484
+146
+43% +$4.55K ﹤0.01% 285
2019
Q1
$12K Hold
338
﹤0.01% 251
2018
Q4
$10K Buy
338
+233
+222% +$10K ﹤0.01% 242
2018
Q3
$7K Sell
105
-26
-20% -$1.69K ﹤0.01% 247
2018
Q2
$9K Buy
+131
New +$8.22K ﹤0.01% 100
2018
Q1
Sell
-131
Closed -$9K 388
2017
Q4
$9K Hold
131
﹤0.01% 472
2017
Q3
$8K Buy
+131
New +$6.4K ﹤0.01% 487

Other funds holding OVV

Balentine LLC's OVV Position: Q2 2024 in Review

Balentine LLC sold out of Ovintiv (OVV) in Q2 2024, closing a stake of 4,689 shares — an estimated $243K sold.

Balentine LLC first reported a position in OVV in Q3 2017 and held it in 21 quarters. The position peaked at $319K in Q1 2022. 548 funds tracked by Wall St. Rank hold OVV as of Q2 2024.

  • Balentine LLC reported no remaining Ovintiv position as of Q2 2024 after selling out during the quarter.
  • Balentine LLC sold 4,689 Ovintiv shares in Q2 2024, an estimated $243K.
  • Balentine LLC first reported a position in Ovintiv in Q3 2017 and held it in 21 quarters.
  • Balentine LLC's Ovintiv position peaked at $319K in Q1 2022.
  • 548 funds tracked by Wall St. Rank held Ovintiv as of Q2 2024.

Based on Balentine LLC's 13F filing for Q2 2024, filed 7 Aug 2024.